| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52660-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75189-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52662-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11976-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-27154-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-27126-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12000-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20156-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52708-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50284-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52655-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81049-0.025mg | |||
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Daclizumab (NBP2-52660, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0006.jpg "Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Daclizumab (NBP2-52660, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - Cynomolgus monkey lymphocytes were stained with an isotype control (red) or the rabbit-chimeric version of Daclizumab (NBP2-52660, blue) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FlowJo single-cell flow cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0004.jpg)
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Rhesus monkey lymphocytes were stained with an isotype control (red) or the rabbit-chimeric version of Daclizumab (NBP2-52660, blue) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FlowJo single-cell flow cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0005.jpg)
![Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Rhesus monkey lymphocytes were stained with an isotype control (NBP2-52636, panel A) or the rabbit-chimeric version of Epratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-hL22-Epratuzumab-Chimeric-Flow-Cytometry-NBP2-75189-img0003.jpg "Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Rhesus monkey lymphocytes were stained with an isotype control (NBP2-52636, panel A) or the rabbit-chimeric version of Epratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Eptratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-hL22-Epratuzumab-Chimeric-Flow-Cytometry-NBP2-75189-img0001.jpg)
![Flow Cytometry: Siglec-2/CD22 Antibody (hL22 (Epratuzumab)) - Chimeric [NBP2-75189] - Flow-cytometry using anti-CD22 antibody Epratuzumab. Cynomolgus monkey lymphocytes were stained with an isotype control (NBP2-52636, panel A) or the rabbit-chimeric version of Epratuzumab (NBP2-75189, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-hL22-Epratuzumab-Chimeric-Flow-Cytometry-NBP2-75189-img0002.jpg)
![Flow Cytometry: CD19 Antibody (HD37) - Chimeric [NBP2-52662] - Flow-cytometry using anti-CD19 antibody HD37. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of HD37 (NBP2-52662, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD19-Antibody-HD37-Chimeric-Flow-Cytometry-NBP2-52662-img0001.jpg "Flow Cytometry: CD19 Antibody (HD37) - Chimeric [NBP2-52662] - Flow-cytometry using anti-CD19 antibody HD37. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of HD37 (NBP2-52662, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Immunocytochemistry/Immunofluorescence: B7-1/CD80 Antibody (RM80) - Chimeric [NBP3-11976] - Immunofluorescence analysis of paraformaldehyde fixed RAW264.7 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of RM80 (NBP3-11976) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11976, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-RM80-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-11976-img0001.jpg "Immunocytochemistry/Immunofluorescence: B7-1/CD80 Antibody (RM80) - Chimeric [NBP3-11976] - Immunofluorescence analysis of paraformaldehyde fixed RAW264.7 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of RM80 (NBP3-11976) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11976, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: CRTAM Antibody (1C11E10) [NBP3-27154] - Analysis of HL-60 cells using CRTAM mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/nbp3-27154_mouse-crtam-mab-1c11e10-bsa-free-1042024917044.jpg%3Fv=1666704393 "Flow Cytometry: CRTAM Antibody (1C11E10) [NBP3-27154] - Analysis of HL-60 cells using CRTAM mouse mAb (green) and negative control (red).")
![Western Blot: CRTAM Antibody (1C11E10) [NBP3-27154] - Analysis using CRTAM mAb against HEK293 (1) and CRTAM (AA: extra 18-287)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/nbp3-27154_mouse-crtam-mab-1c11e10-bsa-free-1042024918195.jpg%3Fv=1666704393)
![ELISA: CRTAM Antibody (1C11E10) [NBP3-27154] - Black line: Control Antigen (100 ng); Purple line: Antigen (10 ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)](http://images.novusbio.com/fullsize/nbp3-27154_mouse-crtam-mab-1c11e10-bsa-free-1042024918193.jpg%3Fv=1666704393)
![Western Blot: CRTAM Antibody (1C11E10) [NBP3-27154] - Analysis using CRTAM mAb against human CRTAM (AA: extra 18-287) recombinant protein. (Expected MW is 56 kDa)](http://images.novusbio.com/fullsize/nbp3-27154_mouse-crtam-mab-1c11e10-bsa-free-1042024917016.jpg%3Fv=1666704393)
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against HEK293 (1) and BAFFR/TNFRSF13C (AA: extra 1-78)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-1042024917029.jpg%3Fv=1666702823 "Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against HEK293 (1) and BAFFR/TNFRSF13C (AA: extra 1-78)-hIgGFc transfected HEK293 (2) cell lysate.")
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against human BAFFR/TNFRSF13C (AA: extra 1-78) recombinant protein. (Expected MW is 34 kDa)](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-10420249181944.jpg%3Fv=1666702823)
![ELISA: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Black line: Control Antigen (100 ng); Purple line: Antigen (10 ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-1042024920234.jpg%3Fv=1666702823)
![Flow Cytometry: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis of Raji cells using BAFFR/TNFRSF13C mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-10420249181918.jpg%3Fv=1666702823)
![Western Blot: CCR5 Antibody (RC-10) - Chimeric [NBP3-12000] - Jurkat (A), Molt4 (B), K562 (C) and Daudi (D) cell lysates (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of RC-10 (NBP3-12000) at 0.0003 ug/ml, 0.001 ug/ml, 0.003 ug/ml and unknown ug/ml, respectively, before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/CCR5-Antibody-RC-10-Chimeric-Western-Blot-NBP3-12000-img0001.jpg "Western Blot: CCR5 Antibody (RC-10) - Chimeric [NBP3-12000] - Jurkat (A), Molt4 (B), K562 (C) and Daudi (D) cell lysates (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of RC-10 (NBP3-12000) at 0.0003 ug/ml, 0.001 ug/ml, 0.003 ug/ml and unknown ug/ml, respectively, before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: CCR5 Antibody (RC-10) - Chimeric [NBP3-12000] - Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of RC-10 (NBP3-12000) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12000, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CCR5-Antibody-RC-10-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12000-img0002.jpg)
![Flow Cytometry: CCR5 Antibody (RC-10) - Chimeric - Azide and BSA Free [NBP3-12000] - Paraformaldehyde fixed human peripheral blood monocytes permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-12000 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-12000_rabbit-monoclonal-ccr5-antibody-rc-10-chimeric-7420252214129.png)
![Immunocytochemistry/Immunofluorescence: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes stained with the chimeric rabbit IgG version of 6E5A7 (NBP3-20156) (1:1000 dilution) for 1h followed by Alexa Fluor(R) 488 secondary antibody (1:1500 dilution), showing nuclear staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-20156, DAPI, merged channels and an isotype control. The isotype control was anti-fluorescein antibody (NBP2-52638) followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-20156_rabbit-nkg2d-cd314-mab-6e5a7-chimeric-azide-bsa-free-2742023924240.png "Immunocytochemistry/Immunofluorescence: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes stained with the chimeric rabbit IgG version of 6E5A7 (NBP3-20156) (1:1000 dilution) for 1h followed by Alexa Fluor(R) 488 secondary antibody (1:1500 dilution), showing nuclear staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-20156, DAPI, merged channels and an isotype control. The isotype control was anti-fluorescein antibody (NBP2-52638) followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Western Blot: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - K562(A) (2ug/ml) and human peripheral blood monocytes(B) (2ug/ml) cells lysate (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of 6E5A7 (NBP3-20156) before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp3-20156_rabbit-nkg2d-cd314-mab-6e5a7-chimeric-azide-bsa-free-2742023924251.png)
![Flow Cytometry: Integrin beta 1/CD29 Antibody (K20) [NBP2-52708] - Flow-cytometry using anti-CD29 antibody K20 (NBP2-52708) Human leukocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of K20 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Integrin-beta-1-CD29-Antibody-K20-NBP2-52708-img0001.jpg "Flow Cytometry: Integrin beta 1/CD29 Antibody (K20) [NBP2-52708] - Flow-cytometry using anti-CD29 antibody K20 (NBP2-52708) Human leukocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of K20 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in Jurkat cell lysates.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-T8P2G4-A6-Western-Blot-NBP2-50284-img0001.jpg "Western Blot: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in Jurkat cell lysates.")
![Immunohistochemistry-Paraffin: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in a hepatocellular carcinoma tissue cross section.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-T8P2G4-A6-Immunohistochemistry-Paraffin-NBP2-50284-img0002.jpg)
![Immunohistochemistry: CD40/TNFRSF5 Antibody (T8P2G4/A6) [NBP2-50284] - Analysis of CD40 in a cross section of human breast cancer tissue. Positive cytoplasmic staining is shown.](http://images.novusbio.com/fullsize/CD40-TNFRSF5-Antibody-T8P2G4-A6-Immunohistochemistry-NBP2-50284-img0003.jpg)
![Immunohistochemistry: CD35 Antibody (8C12) [NBP2-81049] - Formalin fixed rat stomach slices were were stained with NBP2-81049 at 3 ug/ml.](http://images.novusbio.com/fullsize/CD35-Antibody-8C12-Immunohistochemistry-NBP2-81049-img0001.jpg "Immunohistochemistry: CD35 Antibody (8C12) [NBP2-81049] - Formalin fixed rat stomach slices were were stained with NBP2-81049 at 3 ug/ml.")